SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD APR 05
MCX SILVER MAR 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD APR 05
MCX SILVER MAR 05
MCX CRUDEOIL MAR 19
MCX NATURALGAS MAR 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

Stock Market Live: Sensex off day's low; Nifty above 14,600; banks, financials drag

Asian stocks slip as global rally skids on inflation fears

Oil prices slip on surprise build in US crude stocks

Rupee tanks 67 paise to 73.10 against US dollar in early trade

Looking at quarterly run rate of $140 mn in US market: Cipla

Updated : November 10, 2020 11:46 AM IST

Cipla’s second quarter performance exceeded analyst estimates on most parameters. Umang Vohra, MD and Global CEO of Cipla discussed the numbers in an interview with CNBC-TV18.

Talking about growth sustaining in second half of the year Vohra said, “The numbers are in response to the market forces and I do think these numbers in a certain range will continue to exist going forward at least for the next one quarter.”

“There might be a marginal dip or off in revenue or in profit but by and large we are on this trajectory for the current quarter as well,” he said.

On the outlook for the India business he said, “I would like to believe the COVID portfolio growth will begin to abate as cases go down in India so we are seeing cases coming down. Other than COVID our businesses are fairly strong on its fundamentals. We believe we can expand our margin trajectory by about 300 basis points from the start of the year on a normalise basis to where we think we would be in 2-3 years.”

Talking about US markets Vohra said, “Approximately 140 ($140 million) is now the new base of the US and as we launch new products this run rate would increase.

“The Albuterol category is fairly large category, Perrigo was in the market till about month and a half back, and Perrigo will be back in the market soon as well. I think the arrival and the departure of player may create a little bit of short term pressure in volumes, but I don’t think the prices would correct as significantly because of Perrigo’s arrival back into the market.”

To know more about the company's Q2 performance, watch the video.

You May Also Like

Sensex plunges over 1,700 points: Key reasons behind the market rout

Sensex plunges over 1,700 points: Key reasons behind the market rout

India’s GDP growth estimated at 1.8% in Q3: HSBC India

India’s GDP growth estimated at 1.8% in Q3: HSBC India

Bharat Bandh: Traders, transporters on 1-day strike on Feb 26 against rising fuel prices, E-Way Bill

Bharat Bandh: Traders, transporters on 1-day strike on Feb 26 against rising fuel prices, E-Way Bill

Trending on CNBC-TV18

Live TV

recommended for you